Randomized Multicenter Study to Assess Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin Monotherapy for Treatment of Methicillin Resistant Staphylococcus Aureus Bacteremia in Hospitalized Patients
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2018
Price : $35 *
At a glance
- Drugs Daptomycin (Primary) ; Fosfomycin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 16 Jan 2018 Status changed from recruiting to completed.
- 18 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 18 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.